Drug nonadherence prevalent in type 2 diabetes patients

07/25/2013 | InternalMedicineNews.com (free registration)

Research presented at the ADA 73rd Scientific Sessions showed the one-year drug discontinuation rate among type 2 diabetes patients was 89% in those taking a GLP-1 agonist, 82% in those who took a DPP-4 inhibitor and 84% in those treated with other diabetes drugs. The findings highlight the need for better persistence with GLP-1 agonist therapy, the lead researcher said.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL